Studies on the effect of clinical dosages of chlorpromazine and other neurotropics on primaquine-sensitive Negro mental patients.
D000328:Adult; D001741:Black or African American; D000743:Anemia, Hemolytic / Q000453:epidemiology*; D002746:Chlorpromazine / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003704:Dementia / Q000097:blood; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000453:epidemiology*; D005978:Glutathione / Q000097:blood; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D008297:Male; D009497:Neurotic Disorders / Q000097:blood; D011319:Primaquine / Q000009:adverse effects*; D011600:Psychopharmacology; D011604:Psychoses, Alcoholic / Q000097:blood; D012559:Schizophrenia / Q000097:blood
D005978:Glutathione; D011319:Primaquine; D002746:Chlorpromazine